Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 2.85 | (900.18) | (119.68)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 56.40 | (994.92) | (111.02)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| AstraZeneca to invest $2bn in Summit Therapeutics | 29-Sep-2026 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 14.15 |
| Change Today | $ -0.93 |
| % Change | -6.14 % |
| 52 Week High | $25.42 |
| 52 Week Low | $12.62 |
| Volume | 5,555,312 |
| Shares Issued | 14.06m |
| Market Cap | $198.99m |
| Beta | 0.00 |
| RiskGrade | 579 |
| Strong Buy | 5 |
| Buy | 7 |
| Neutral | 5 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $14.15 |
| 15:59 | 200 @ $14.15 |
| 15:59 | 364 @ $14.15 |
| 15:59 | 200 @ $14.15 |
| 15:59 | 100 @ $14.15 |
You are here: research